Haemophilia trials in Oman

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  Where

  Muscat

  Age

  1 year to 74 years

  People

  245 worldwide

  Run by

  Pfizer

  See details and how to joinNCT05145127 · EU 2022-500470-33-00